Disc Medicine · 2 months ago
Director, Strategic Accounts, Central
Central US
Full-time
Hybrid
Director/Executive
$207K/yr - $281K/yr
12+ years expDisc Medicine is a clinical-stage biopharmaceutical company focused on developing novel treatments for hematologic diseases. The Director of Strategic Accounts will execute market access strategies to ensure patient access to Disc’s therapies by managing relationships with payers and collaborating with internal teams to address access challenges.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Seamlessly implement access strategies for assigned national/regional commercial and government payers, as well as PBM and payer GPO customers, to ensure appropriate patient access to Disc’s therapies
Lead engagements with assigned national/regional commercial and government payers, along with PBM and payer GPO customers, to secure favorable coverage policies ensuring patient access
Drive the execution of brand access strategies across teams responsible for regional affiliates and custom clients of national vertically integrated payers, PBM, and GPO PBM customers
Maintain and foster relationships with senior managed care medical and pharmacy executives by leveraging expert knowledge of the customer’s organizational structure and strategic priorities
Leverage internal resources and subject matter experts (e.g., HEOR, Medical) to effectively communicate the value of Disc’s portfolio to national, vertically integrated payers, PBM, and GPO customers
Pilot holistic customer strategies to engage all aspects of large vertically integrated national customers
Educate internal cross-functional teams on payer coverage policies to enhance strategic planning, execution, and business knowledge
Promote cross-functional collaboration with internal stakeholders to align strategies and optimize access solutions
Collaborate with market access, patient services sales/brand team colleagues, and patient advocacy, to develop strategies and ensure execution against threats and opportunities in their region
Engage national payer accounts to present product value, conduct disease state education for pipeline products, perform pre-approval information exchange (PIE) engagements
Provide insights to internal stakeholders (e.g., medical liaisons) on customer-specific priorities to inform access strategy
Engage cross-functional stakeholders (e.g., HEOR) in customer meetings to ensure comprehensive and effective communication
Gather information and create analyses to enhance the organization's understanding of current and emerging payer market dynamics, risks, and competitive behaviors, with a focus on identifying potential business impacts
Qualification
Required
Bachelor's Degree in related business, healthcare or scientific discipline
12-15 years' experience in Market Access in the biopharmaceutical/pharmaceutical industry
5+ years' experience in an account management role with responsibility for payer and PBM customers
Successful experience launching, securing, and maintaining “to label or better” pharmacy/medical benefit access in a rare disease market
Experience negotiating with payers and/or PBMs
Expert knowledge of U.S. managed markets including commercial and government payers
Demonstrated success in securing appropriate coverage for specialty medicines covered under the pharmacy benefit and medical benefit
Excellent collaboration, written, and verbal communications skills
Clinical, technical, and scientific knowledge and aptitude in complex disease states
Travel requirements: Willing to travel at least 60% of the time
Benefits
Comprehensive benefits
Competitive compensation packages
Flexible work environment
Company
Disc Medicine
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.29BKey Investors
Hercules CapitalFrazier Life SciencesBain Capital Life Sciences
2025-10-21Post Ipo Secondary· $25M
2025-10-21Post Ipo Equity· $225M
2025-01-22Post Ipo Equity· $225.5M
Leadership Team
John Quisel
Chief Executive Officer
Jean Franchi
Chief Financial Officer
Recent News
2026-01-17
2026-01-16
Company data provided by crunchbase